Homeopathic Cold Medicine for Children

University of Washington50 enrolled

Overview

The purpose of this study is to determine if a commercially available homeopathic cold remedy for children is effective in providing relief from cold symptoms in children 2-5 years old. It is postulated that children will have relief of symptoms after receiving a dose of the cold remedy

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Upper Respiratory Tract Infection

Interventions

Hyland's Cold 'n Cough 4 KidsDRUG

Liquid homeopathic cold remedy, 5 ml by mouth every 4 hours as needed for relief of cold symptoms for up to 10 days

Eligibility

Sex: ALLMin age: 24 MonthsMax age: 59 Months

Medical Language ↔ Plain English

Inclusion Criteria: * Children 24-59 months old * Cold/cough symptoms of \<7 days duration * Diagnosed with upper respiratory tract infection by physician or nurse practitioner * Parent who speaks and reads English Exclusion Criteria: * Use of chronic medication other than multivitamins * History of asthma * Medication other than acetaminophen or ibuprofen * Use of homeopathic remedy within preceding 30 days * Only 1 participant per family

Locations (1)

University of Washington Medical Center-Roosevelt Pediatric Care Center

Seattle, Washington, United States

Outcomes

Primary Outcomes

Relief of Upper Respiratory Tract Infection (URI) Symptoms (Cough, Runny Nose, Nasal Congestion, Sneezing)1 Hour After Dose of Homeopathic Remedy.

For each dose of study medication, parents indicated which of the symptoms were present (runny nose, cough, nasal congestion, sneezing). Parents rated change in each symptom present one hour after a dose of study medication for up to 6 doses in study logs. Responses were dichotomized as at least some improvement or better (improvement) vs. no improvement or worse. The outcome measure is number of times that improvement in a specific symptom was noted after a dose of the homeopathic remedy. Completed study logs were received from 37 of 49 enrolled participants.

Time frame: up to 10 days from index visit

Secondary Outcomes

Parental Report of an Adverse Event After a Dose of Study Medication

After each dose of study medication parents reported the presence of any adverse events

Time frame: data collected after doses occurring up to 10 days after index visit

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.